Clinical Trial Update: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating TQH2722 Injection for moderate-to-severe atopic dermatitis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• TQH2722 Injection (TQH2722)

Snippet

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Conditions: Atopic Dermatitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING